Improving treatments for antibiotic-resistant bacterial infections
Official title: Task C24: Process Optimization and Scale Up of an Antibiotic-Resistant Bacterial Agent
Funded at Albany Molecular Research, INC. · NIH-11178795 · Data updated 2026-11-12
This study is working on creating new treatments for tough infections caused by antibiotic-resistant bacteria, like Acinetobacter and Pseudomonas aeruginosa, to help patients who currently have limited options for effective care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project start | July 19, 2024 |
| Project end | January 18, 2026 |
| Funding year | 2024 |
| Award (this year) | $1,905,868 |
| NIH project number | 272201800008I-0-759302400001-1 |
| Project ID | NIH-11178795 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
✕Less likely to help
Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.
What this research studies
This research focuses on developing new therapeutic agents to combat antibiotic-resistant bacteria, specifically targeting pathogens like Acinetobacter and Pseudomonas aeruginosa. The approach involves optimizing processes for creating these agents, including planning, evaluation, and manufacturing under good practices. The research will also assess the safety and effectiveness of these agents through laboratory testing. Patients may benefit from new treatment options that are effective against infections that are currently difficult to treat due to resistance.
Why it matters
Potential benefit: If successful, this research could lead to new antibiotics that effectively treat infections caused by resistant bacteria.
How similar studies have gone: Other research has shown promise in developing new antibiotics targeting resistant bacteria, indicating that this approach has potential for success.
Where this research is happening
-
Albany Molecular Research, INC.
Albany, United States Active
Researchers
- Principal investigator: Schlager, Heidi — Albany Molecular Research, INC.
- Study coordinator: Schlager, Heidi
Related research
Other NIH-funded projects on the same topics.
-
Accelerating the development of new drugs for neurological conditions
This study is all about finding and creating new medicines for brain-related conditions faster, so that patients can have more treatment options that are safe and effective.
-
Developing new drugs to manage pain and substance use disorders
This study is working on new medications to help people manage pain better and tackle issues with substance use, aiming to create treatments that could improve your quality of life.
-
Developing a new treatment for safety evaluation and clinical trials.
This study is working on a new medicine called NCGC00413972 to make sure it’s safe and effective for people, with the hope that it could offer new treatment options in the future.
-
Investigating ways to improve pain management and drug formulation.
This study is all about finding better ways to manage pain by creating new and improved medications, and it’s designed for patients who are looking for effective pain relief options.
-
Developing new treatments for Alzheimer's Disease through medicinal chemistry
This study is exploring new ways to create medications for Alzheimer's Disease that could help patients by targeting the specific processes involved in the condition.
-
Developing a new treatment for safety evaluation and clinical trials.
This study is working on a new treatment called NCGC00413972 to make sure it's safe and effective for people, with the hope that it could offer new options for patients in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.